Given the projected NPAT from Covid ARDs by the zealots of $1B NPAT by 2021, Rem-L is gone for just US$25m upfront (as $25m was equity according to ann).
All the other "big numbers" like $500m have no detail. CYP has GvHD at $100m alone...
So the Osiris landfill has been partnered....for peanuts of market cap, and costs to date.
and how much of this goes to Osiris tech owners? No detail as usual.
The rest of Rem-L is 50/50% basis.
Mesoblast and Novartis collaboration, page-2
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $43.11M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.5¢ | $14.74K | 61.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 96221 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
0.005 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 6875 | ||
| Last updated 10.47am 03/05/2024 ? | |||||
| CYP (ASX) Chart |